Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07739719) titled 'SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)' on July 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: McMaster University
Condition:
Influenza (Healthy Volunteers)
Intervention:
Biological: LAIV FLUMIST
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 15, 2026
Target Sample Size: 966
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrials.gov/study/NCT07739719...